top of page
The Professional Network for Healthcare Experts
FDA approves Welireg plus Lenvima for advanced clear-cell renal cell carcinoma after immunotherapy
The FDA has approved Welireg in combination with Lenvima for adults with advanced clear-cell renal cell carcinoma following prior PD-1 or PD-L1 immunotherapy.
nuaxia
7 days ago2 min read
FDA backs Merck’s dual-pronged push in kidney cancer with Welireg–Keytruda combo approval
The US Food and Drug Administration (FDA) has approved a combination regimen of Merck & Co.’s Keytruda (pembrolizumab) and Welireg (belzutifan).
nuaxia
Jun 152 min read
bottom of page